Results 71 to 80 of about 877 (137)
Background. Bioprosthetic mitral valves frequently undergo severe calcification causing bioprosthetic valve failure, an urgent problem in cardiovascular surgery.
Мария Владимировна Хуторная +7 more
doaj
Background The optimal antithrombotic strategy early after aortic valve replacement surgery with a biological valve remains controversial due to lack of high-quality evidence.
Tomislav Kopjar +6 more
doaj +1 more source
Key Clinical Message Underexpansion of an aortic bioprosthetic valve is common after transcatheter aortic valve replacement (TAVR). Significant discrepancy between invasive hemodynamic gradients and echocardiographic Doppler gradients in an underexpanded
Imad Hameedullah +3 more
doaj +1 more source
Background Bioprosthetic valve thrombosis is previously considered as an extremely rare complication which hasn’t been systemically recognized and understood.
Jingya Fan, Peng Teng, Yu Zou, Liang Ma
doaj +1 more source
Background Selecting between mechanical and bioprosthetic valves depends on multiple clinical and patient-specific criteria. This study aims to compare mechanical and bioprosthetic valve replacement outcomes in Egypt to support evidence-informed decision-
Mohamed El Fiky +12 more
doaj +1 more source
Expanding Indications for Bioprosthetic Valve Fracture and Bioprosthetic Valve Remodeling [PDF]
Adnan K. Chhatriwalla, Paul Sorajja
openaire +1 more source
Background Heart valve diseases affect over 100 million people globally, with mitral regurgitation being the most common in developed countries. Bioprosthetic heart valves, frequently used for replacement, typically last 10–15 years before degeneration ...
Yakup Alsancak +4 more
doaj +1 more source
A 70-year-old female patient with a history of bioprosthetic aortic valve replacement and coronary artery bypass graft presented with bioprosthetic valve failure secondary to prosthetic valve endocarditis. The patient was deemed unsuitable for surgery by
Yuhan Zhou +3 more
doaj +1 more source
. A 76-year-old female with rheumatic heart disease presented with progressive dyspnea 12 years after dual surgical bioprosthetic valve replacement (mitral: 25 mm; aortic: 21 mm).
Jiandong Ding +8 more
doaj +1 more source
ObjectiveTo understand the factors that influence rheumatic heart disease (RHD) patients' prosthetic heart valve choice, their knowledge of anticoagulation and subsequent experience.
Shownok Saha +7 more
doaj +1 more source

